AVITA MED LTD/S ADR (NASDAQ:RCEL) shares hit a new 52-week high during trading on Thursday . The company traded as high as $8.90 and last traded at $8.81, with a volume of 4905 shares. The stock had previously closed at $7.87.

The company has a market capitalization of $621.31 million, a P/E ratio of -22.14 and a beta of 1.28.

About AVITA MED LTD/S (NASDAQ:RCEL)

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin.

Featured Article: Most Volatile Stocks – What Investors Need to Know to Maximize ROI

Receive News & Ratings for AVITA MED LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA MED LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.